DK105680A - Fremgangsmaade til fremstilling af peptider - Google Patents

Fremgangsmaade til fremstilling af peptider

Info

Publication number
DK105680A
DK105680A DK105680A DK105680A DK105680A DK 105680 A DK105680 A DK 105680A DK 105680 A DK105680 A DK 105680A DK 105680 A DK105680 A DK 105680A DK 105680 A DK105680 A DK 105680A
Authority
DK
Denmark
Prior art keywords
image
tyr
inhibiting
release
peptides
Prior art date
Application number
DK105680A
Other languages
English (en)
Inventor
D F Veber
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK105680A publication Critical patent/DK105680A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK105680A 1979-03-13 1980-03-12 Fremgangsmaade til fremstilling af peptider DK105680A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/020,148 US4190648A (en) 1979-03-13 1979-03-13 Peptides having somatostatin activity

Publications (1)

Publication Number Publication Date
DK105680A true DK105680A (da) 1980-09-14

Family

ID=21797013

Family Applications (1)

Application Number Title Priority Date Filing Date
DK105680A DK105680A (da) 1979-03-13 1980-03-12 Fremgangsmaade til fremstilling af peptider

Country Status (6)

Country Link
US (1) US4190648A (da)
EP (1) EP0017746B1 (da)
JP (1) JPS55124747A (da)
AT (1) ATE2318T1 (da)
DE (1) DE3061721D1 (da)
DK (1) DK105680A (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE3062075D1 (en) * 1979-11-27 1983-03-24 Sandoz Ag Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
DD155985A5 (de) * 1979-12-21 1982-07-21 Ciba Geigy Ag Verfahren zur herstellung cyclischr octapeptide
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
DE3379657D1 (en) * 1982-12-06 1989-05-24 Merck & Co Inc Dicyclic hexapeptides, processes for their preparation and pharmaceutical compositions containing them
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
US4994554A (en) * 1988-05-11 1991-02-19 Immunobiology Research Institute, Inc. Probursin
US5504069A (en) * 1993-02-11 1996-04-02 Biomeasure, Inc. Inhibition of trauma-induced tumor growth
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
EP0981364B1 (en) * 1997-05-13 2006-03-01 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Method and compositions for treating hyperlipidemia
CA2290592A1 (en) * 1997-05-13 1998-11-19 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for decreasing body weight
CA2289499C (en) * 1997-05-13 2010-02-23 Michael Anthony Cawthorne Somatostatin and somatostatin agonists for treating insulin insensitivity and syndrome x
US6004928A (en) * 1997-05-13 1999-12-21 Biomeasure, Incorporated Method of treating hyperlipidemia
US5968903A (en) * 1998-05-07 1999-10-19 Biomeasure, Incorporated Inhibition of H. pylori proliferation
NZ530007A (en) 2001-06-08 2006-02-24 Sod Conseils Rech Applic Somatostatin-dopamine chimeric analogues that retain both somatostatin and dopamine activity in vivo and display enhanced biological activity
CA2523197C (en) 2003-04-22 2016-05-24 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Peptide vectors
WO2009150470A2 (en) 2008-06-12 2009-12-17 Syntaxin Limited Suppression of cancers
EP2310028B1 (en) 2008-06-12 2016-11-16 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47421B1 (en) * 1977-06-08 1984-03-07 Merck & Co Inc Somatostatin analogs,process for their preparation and pharmaceutical compositions containing them
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
US4140767A (en) * 1977-12-01 1979-02-20 Merck & Co., Inc. Somatostatin analogs

Also Published As

Publication number Publication date
EP0017746A1 (en) 1980-10-29
US4190648A (en) 1980-02-26
JPS55124747A (en) 1980-09-26
EP0017746B1 (en) 1983-01-26
ATE2318T1 (de) 1983-02-15
DE3061721D1 (en) 1983-03-03

Similar Documents

Publication Publication Date Title
DE3061721D1 (en) Peptides having somatostatin activity, compositions comprising them and process for making the peptides
IE781151L (en) Somatostatin analogs
US4563352A (en) Human pancreatic GRF
EP0301087B1 (en) Peptide
US4435385A (en) N-Acyl-polypeptides and processes for the production thereof
JPH0133118B2 (da)
DK165749B (da) Grf-analoge peptider og farmaceutisk acceptable salte heraf samt farmaceutisk middel indeholdende disse
ES531585A0 (es) Un procedimiento para preparar peptidos analogos al factor de liberacion de corticotropina
ZA926337B (en) Polypeptide analogues having growth hormone releasing activity.
HUT63855A (en) Process for producing salts of lh-rh analogous compounds and pharmaceutical compositions comprising such salts
RU98104253A (ru) Новые опиоидные пептиды
KR920014828A (ko) 신규한 종양 성장-억제 소마토스타틴 동족체, 이 동족체를 함유하는 제약 조성물 및 그 제조방법
DK167361B1 (da) Grf-analoge peptider, farmaceutisk acceptable salte heraf og fremgangsmaader til fremstilling af disse
KR900006560B1 (ko) Grf 유사체의 제법
KR927002373A (ko) 성장 호르몬 분비 활성을 갖는 폴리펩타이드 화합물
RU97107089A (ru) Полипептидные соединения, содержащие d-2-алкилтриптофан, стимулирующий высвобождение гормона роста
US4428942A (en) Analogs of somatostatin
AU646451B2 (en) Hybrid calcitonin
KR0163033B1 (ko) Grf 유사체 viia
EP0107890B1 (en) Mammalian pgrf
US4703035A (en) Human pancreatic GRF amidated fragments
EP0001449B1 (de) Somatostatinanaloge und diese enthaltende pharmazeutische Präparate sowie deren Herstellung
EP0063885B1 (en) Analogs of extended n-terminal somatostatin
Reubi Somatostatin receptors as markers for endocrine tumors
GB2019411A (en) Peptides Related to Somatostatin